CABERGOLINA Y EMBARAZO PDF

La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Marg Mikanos
Country: Papua New Guinea
Language: English (Spanish)
Genre: Art
Published (Last): 14 October 2011
Pages: 220
PDF File Size: 9.68 Mb
ePub File Size: 13.67 Mb
ISBN: 990-1-68901-196-3
Downloads: 10449
Price: Free* [*Free Regsitration Required]
Uploader: Dit

Primary medical therapy of micro- and macroprolactinomas in men. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women.

Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea.

Indian J Med Res. Cagergolina un estudio no cabervolina especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. Su principal desarrollo es la base de datos Epistemonikos www. Diagnosis and treatment of yperprolactinemia: We combined the evidence using meta-analysis and generated a summary of findings following the GRADE approach.

Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed.

Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing Cabergolinw. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials. N Engl J Med.

Cabergoline or bromocriptine for prolactinoma?

Pakistan Journal of Medical Sciences Online. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma.

La bromocriptina se asocia a mayores efectos adversos que cabergolina. Sobre los desenlaces incluidos en este resumen. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.

[Update on endocrinology: management of prolactinomas during pregnancy].

Results of a national multicenter randomized double-blind study]. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media. Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma.

Todos los estudios compararon bromocriptina versus cabergolina. Cabergoline or bromocriptine for prolactinoma?. Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine. De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral.

In the absence of menstrual period, the drug should be discontinued and confirm pregnancy.

Dostinex y embarazo múltiple

In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible. In emnarazo the ophthalmologic examination is no formal indication.

Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: J Clin Endocrinol Metab. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. It is not clear whether cabergoline is cabbergolina more effective with respect to tumor growth because the certainty of the evidence is very low. Medwave se preocupa por su privacidad y la seguridad de sus datos personales.

The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. There is evidence that breastfeeding no increased risk for tumor growth. Cabergoline Comparative Study Group. However, it is not clear if this translates into clinical benefits. Middle East Fertility Society Journal. The hyperprolactinemia is associated with anovulation and infertility.